본문으로 건너뛰기
← 뒤로

Management of oral secretions in neurological disease.

Practical neurology 2017 Vol.17(2) p. 96-103

McGeachan AJ, Mcdermott CJ

관련 도메인

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA McGeachan AJ, Mcdermott CJ (2017). Management of oral secretions in neurological disease.. Practical neurology, 17(2), 96-103. https://doi.org/10.1136/practneurol-2016-001515
MLA McGeachan AJ, et al.. "Management of oral secretions in neurological disease.." Practical neurology, vol. 17, no. 2, 2017, pp. 96-103.
PMID 28188210

Abstract

Sialorrhoea is a common and problematic symptom that arises from a range of neurological conditions associated with bulbar or facial muscle dysfunction. Drooling can significantly affect quality of life due to both physical complications such as oral chapping, and psychological complications such as embarrassment and social isolation. Thicker, tenacious oral and pharyngeal secretions may result from the drying management approach to sialorrhoea. The management of sialorrhoea in neurological diseases depends on the underlying pathology and severity of symptoms. Interventions include anticholinergic drugs, salivary gland-targeted radiotherapy, salivary gland botulinum toxin and surgical approaches. The management of thick secretions involves mainly conservative measures such as pineapple juice as a lytic agent, cough assist, saline nebulisers and suctioning or mucolytic drugs like carbocisteine. Despite a current lack of evidence and variable practice, management of sialorrhoea should form a part of the multidisciplinary approach needed for long-term neurological conditions.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1

MeSH Terms

Botulinum Toxins, Type A; Cholinergic Antagonists; Disease Management; Humans; Nervous System Diseases; Radiotherapy, Adjuvant; Sialorrhea

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

같은 제1저자의 인용 많은 논문 (1)

관련 논문